A mutation in the nuclear speckle and splicing factor SRRM2 is associated with multisystem proteinopathy and causes dysregulation of synapse-associated genes
RNA · 2026-09 · 32 (9) · 1436-1452
DOI: 10.1261/rna.080836.125 ↗Kurz gefasst
Fachartikel in der Zeitschrift RNA, online erschienen am 17.06.2026. Verfasst von Qingyu Shi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada. Hauptthemen laut MEDLINE: RNA-Binding Proteins, Synapses, Mutation, Nerve Tissue Proteins. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Multisystem proteinopathy (MSP) is a pleiotropic degenerative disorder which affects the nervous system, muscles, and bones. The identification of risk factors and their molecular contribution to MSP expands our understanding of disease mechanisms. Here, we describe a family with dominantly inherited MSP, in which a mutation in the serine/arginine repetitive matrix protein 2 gene ( SRRM2) that co-segregates with disease, is identified. SRRM2 is essential for nuclear speckle formation and a constitutive member of the RNA splicing machinery. To investigate how the mutation in SRRM2 might contribute to MSP pathogenesis, we examined its effect on a model cell line, where the point mutation was introduced in the endogenous gene. Surprisingly, we found that the resulting single amino acid exchange led to the loss of protein–protein interaction between SRRM2 and the splicing factor ACIN1. Transcriptome studies further revealed widespread differential gene expression, which converged on the dysregulation of synapse-associated pathways. Together, our findings identify SRRM2 as a novel MSP risk factor and provide mechanistic insights into how its mutation can be linked to MSP pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of Toronto, Toronto, Ontario M5S 3H6, Canada.
- School of Chemistry, University of Edinburgh, Edinburgh EH9 3FJ, United Kingdom.
- Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-3678, USA.
- Department of Neurology and ALS Center, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
- School of the Environment, University of Toronto, Toronto, Ontario M5S 3E8, Canada.
- Structural Genomics Consortium, University of Toronto, Toronto, Ontario M5G 1L7, Canada.
Zitieren
APA
Shi, Q., Lauder, C., Miller, J. M., Wang, Y. D., Elsakrmy, N., Volkanoska, S., Freibaum, B. D., Wuu, J., Benatar, M., Peng, H., Kim, H. J., Taylor, J. P., & Cui, H. (2026). A mutation in the nuclear speckle and splicing factor SRRM2 is associated with multisystem proteinopathy and causes dysregulation of synapse-associated genes. RNA, 32(9), 1436-1452. https://doi.org/10.1261/rna.080836.125
Vancouver
Shi Q, Lauder C, Miller JM, Wang YD, Elsakrmy N, Volkanoska S, et al. A mutation in the nuclear speckle and splicing factor SRRM2 is associated with multisystem proteinopathy and causes dysregulation of synapse-associated genes. RNA. 2026;32(9):1436-1452. doi:10.1261/rna.080836.125
BibTeX
@article{Shi2026,
author = {Shi, Qingyu and Lauder, Chloe and Miller, Jolie M and Wang, Yong-Dong and Elsakrmy, Noha and Volkanoska, Sofija and Freibaum, Brian D and Wuu, Joanne and Benatar, Michael and Peng, Hui and Kim, Hong Joo and Taylor, J Paul and Cui, Haissi},
title = {A mutation in the nuclear speckle and splicing factor SRRM2 is associated with multisystem proteinopathy and causes dysregulation of synapse-associated genes},
journal = {RNA},
year = {2026},
volume = {32},
number = {9},
pages = {1436--1452},
doi = {10.1261/rna.080836.125}
}
EUVIMED